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Abstract
Background: Enterococcus spp. are part of the normal flora of humans and animals. The nosocomial pathogenicity of Enterococcus
spp. has emerged in recent years and has caused great concern due to developing of resistance to many antimicrobial agents.
Objectives: The current study aimed to determine the resistance pattern and the type of virulence genes in Enterococcus spp. iso-
lated from Milad hospital of Tehran, Iran.
Materials and Methods: The current observational study was conducted from Apr 2014 to Feb 2015 on a total of 149 Enterococcus
species isolated from Milad hospital in Tehran, Iran. The antibiotic susceptibility pattern of the bacteria was determined by the disc
diffusion method for eight antibiotics. Minimum inhibitory concentration (MIC) of vancomycin was also done using agar-dilution
assay by clinical and laboratory standards institute (CLSI) recommendations. The sodA, esp, cyl, ace and gelE genes were detected by
polymerase chain reaction (PCR) assay.
Results: About 37.5%, 73%, 86.6%, 35.8%, 69%, 60.8%, 45% and 79% of the isolates were resistant to vancomycin, tetracycline, gentam-
icin, chloramphenicol, ciprofloxacin, penicillin, ampicillin and erythromycin, respectively. MIC on 38% of the isolates was≥ 256
µg/mL. Although, the prevalence of vancomycin-resistant Enterococcus (VRE) strains belonged to two species, E. faecium showed high
resistance to a broad range of antibiotics. In total, 94 isolates were positive for esp, and 59, 48 and 3 isolates were positive for ace,
cylA and gelE, Respectively.
Conclusions: The results of the current study designate the important role of medical samples as reservoirs of resistance induc-
ing elements. Early detection of VRE with their virulence trait will help to prevent the spread of vancomycin resistant Enterococcus
species. Supervision for antibiotic usage in hospitals, especially for last option antibiotics, can prevent the spread of resistant iso-
lates and losing all treatment options in the future.
Keywords: Antimicrobial Resistance, Virulence Factors, Enterococcus spp
1. Background
Enterococcus spp. are part of the normal flora of gas-
trointestinal tract, biliary tract, anterior urethra and fe-
male genital tract in both human and animal. These are
important global causes of nosocomial infection disease
(1). Two sources of infections with Enterococcus spp. are
proposed: first, infections may be caused by Enterococcus
species of patient’s flora; second, infections may be caused
by Enterococcus spp. acquired from hospital environments.
Two common Enterococcus species isolated from nosoco-
mial infections are E. faecium and E. faecalis.Enterococcus
strains resistant to different antibiotics are a great public
health problem, especially species isolated from hospital-
acquired infections (1, 2). Enterococcus faecalis is responsi-
ble for 80% - 90% and Enterococcus faecium for the remain-
ing human enterococcal infections (3-5). In 2005, there
were 7066 infectious cases caused by Enterococcus species
in the UK, which 28% were antibiotic resistant (6, 7). These
microorganisms are reported as the second leading cause
of nosocomial urinary tract infections, and the third lead-
ing cause of nosocomial bacteremia in hospitalized pa-
tients (1, 2, 6). Vancomycin-resistant Enterococcus (VRE) is
established as a significant nosocomial pathogen since it
was first reported 20 years ago. VRE are one of the most
important nosocomial pathogens worldwide; they are also
one of the most troublesome pathogens in hospitals in the
United States and are increasing in European health insti-
tutions (6, 8, 9). In addition, the prevalence of VRE among
clinical Enterococcus isolates is increasing rapidly (9). Colo-
nization with VRE can lead to serious diseases such as uri-
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nary tract infections, bacteremia and endocarditis which
many of them such as VRE sepsis can be fatal (9-11). VRE have
prolonged survival on hands, gloves, and environmental
surfaces which consequently can be transmitted to the pa-
tients (12). It is believed that nosocomial enterococci might
have virulence elements that increase their ability to col-
onize hospitalized patients (13, 14). Enterococcus spp. may
carry various genes that directly or indirectly contribute to
virulence (15, 16).
Virulence factors of Enterococcus spp. may contribute
to competition with other bacteria, colonization of the
host, resistance against defense mechanisms of the host
and production of pathological changes directly through
production of toxins or indirectly through induction of in-
flammation (17, 18).
The presence of genes encoding virulence factors in-
cluding collagen-binding protein (ace), aggregation sub-
stance (asa1), cytolysin (cylA), endocarditis antigen (efaA),
enterococcal surface protein (esp), gelatinase (gelE) and
hyaluronidase (hyl), is analyzed in recent years (19, 20).
The extracellular surface protein (Esp), encoded by the
esp gene, is a cell wall-associated protein which serves as
adhesion for the pathogen to host tissue colonization and
persistence in urinary tract infections (21),while aggrega-
tion substances encoded by asa1 are responsible for in-
creased bacterial adhesion to renal tubular cells and heart
endocardial cells (16).
2. Objectives
The current study aimed to determine the antimicro-
bial resistance pattern of Enterococcus spp. by disc diffu-
sion test (DDT) and minimum inhibitory concentration
(MIC), and investigate the prevalence of virulence genes
encoding gelatinase (gelE), collagen adhesion (ace), cy-
tolysin (cylA) and enterococcal surface protein (esp) in En-
terococcus species isolated from Milad hospital in Tehran,
Iran.
3. Patients and Methods
3.1. Sampling Method
In the current study, a total of 149 Enterococcus spp. iso-
lates were collected from different wards, such as inten-
sive care unit (ICU), emergency and surgery rooms, of Mi-
lad hospital in Tehran, from Apr 2014 to Feb 2015. Various
clinical samples via urine, blood, pus, stool, fluids and as-
pirates were collected aseptically from admitted patients;
then the samples were kept at 4°C until processing. It is
noteworthy that, Milad hospital is the largest state spe-
cialized and sub-specialized hospital in Iran with 1000 li-
censed beds.
3.2. Isolation and Phonotypical Identification
The isolates were identified to genus and species level
using clinical and laboratory standards institute (CLSI)
guidelines. Specimens were transferred to the hospital
laboratory and cultured on selective M-Enterococcus agar
(Merck, Germany) with 2, 4 and 8 µg/mL vancomycin.
All of the samples were cultured on bile-esculin-agar
(Merck, Germany). Enterococcus genus was identified using
colony morphology, Gram staining, catalase, pyrolidonyl
aminopeptidase (PYR) and 6.5% salt tolerance tests. Species
were identified using mannitol, sorbitol, arabinose, lac-
tose, methyl-alpha-glucopyranoside and motility tests. Re-
actions were observed after 24 hours of incubation at 37°C.
Results were later confirmed by PCR.
3.3. Antibiotic Susceptibility Tests
The antimicrobial susceptibility of the strains was de-
termined using the disk diffusion method according to
the CLSI guidelines for the following antimicrobial agents
(Mast, UK): ampicillin (10µg), penicillin (10 units), gentam-
icin (10µg), ciprofloxacin (5µg), erythromycin (15µg), van-
comycin (30µg) tetracycline (30µg) and chloramphenicol
(30µg) .Considering the increasing rate of vancomycin re-
sistant Enterococcus species in clinical isolates worldwide,
the MICs of vancomycin were determined using the agar
dilution method based on the CLSI (2013) guidelines. Ente-
rococcus faecalis (ATCC 29212) was used as control strain to
perform antimicrobial tests. Vancomycin was tested in the
range of 0.25 - 256 µg/mL. All of the tests were performed
in duplicate. Muller Hinton agar was supplemented with
different concentrations of vancomycin. Ten microliters
of bacterial culture was spot inoculated after adjusting the
turbidity with McFarland 0.5 standard. The plates were in-
cubated at 37°C for 24 hours and examined for growth. MIC
break points recommended by the CLSI guidelines were
used. MIC≤ 4 was considered as sensitive, MIC between 4 -
32 as intermediate resistant, MIC≥ 32 as resistant and MIC
≥ 256 was considered as highly resistant to vancomycin.
3.4. Polymerase Chain Reaction
PCR assay based on the specific detection of sodA genes
(Table 1) was used to confirm the identification of E. faecalis
and E. faecium.
DNAs of all Enterococcus strains were extracted by the
boiling method as follows: A loopful of overnight Ente-
rococcus culture was suspended in 300 mL of sterile dis-
tilled water; then boiled for 10 minutes and after that cen-
trifuged at 13,000 rpm for 10 minutes. An aliquot of the su-
pernatant (5 mL) was used as the template in a final volume
of 25 mL PCR mixture containing: 13 µL PCR buffer, 2 mM
MgCl2, 200 nM dNTP, 400 nM of each primer and 0.25 U Taq
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Table 1. The Primer Sequences and Expected Size of Amplicons for Each PCR Result
Primer Name Target Gene Oligonucleotide Sequences Product Size, bp
sodA-fcm sodA F: TTGAGGCAGACCAGATTGACG; R: TATGACAGCGACTCCGATTCC 658
sodA-fcl sodA F: ATCAAGTACAGTTAGTCT; R: ACGATTCAAAGCTAACTG 941
gelE gelE F: TATGACAATGCTTTTTGGGAT; R: ATGACAATGCTTTTTGGGAT 213
esp esp F: AGATTTCATCTTTGATTCTTGG; R: AATTGATTCTTTAGCATCTGG 510
cylA cylA F: ACTCGGGGATTGATAGGC; R: GCTGCTAAAGCTGCGCTT 680
Ace ace F: GGAATGACCGAGAACGATGGC; R: GCTTGATGTTGGCCTGCTTCCG 616
DNA polymerase (or 20 µL Master mix PCR). Reactions for
both mixtures were done on a thermal cycler (Sensoquest,
Germany) with an initial denaturation at 95°C for four min-
utes, 30 cycles of amplification (denaturation at 95°C for 30
seconds, annealing at 52°C for one minute, and extension
at 72°C for one minute), and a final extension at 72°C for
seven minutes (22, 23).
The multiplex PCR was performed for three different
genes (gylE, cylA and esp) using specific primers listed in Ta-
ble 1. The multiplex PCR mixture was optimized with total
volume of 50µL composed of 25µL PCR master mix, 0.5µL
of cylA and esp primers and 0.25µL of gelE, 5µL of extracted
DNA and sterile DNA/RNase distilled water up to 50µL (22,
23).
To detect ace gene, a separate conventional PCR was
performed using specific primers for Enterococcus and fol-
lowing the aforementioned protocol for species-specific
PCR; but the annealing temperature was set on 56°C (24,
25). Reactions were performed on thermal cycler with an
initial denaturation at 93°C for seven minutes, followed by
30 cycles of denaturation (94°C for one minute), annealing
(56°C for one minute), extension (72°C for one minute) and
a final extension step at 72°C for 10 minutes.
PCR products were analyzed by electrophoresis on a 3%
agarose gel tainted with ethidium bromide and illustrated
under UV light. Each PCR assay was supplemented with
a negative control, containing all of the reagents without
template DNA.
3.5. PCR Primer Design and Amplification of Putative Virulence
Genes
The primer sequences and expected size of amplicons
for each PCR result are shown in Table 1 (24, 25).
3.6. Statistical Analysis
World health organization (WHO) net, Chi-square and
likelihood ratio analysis were carried out using SSPS soft-
ware version 5.1.
4. Results
Based on the results of various genetic and biochemi-
cal tests, out of 149 isolated strains, two species were identi-
fied. Enterococcus faecalis (60%) followed by E. faecium (26%)
and Enterococcus spp. (14%) were the commonest isolated
species (Table 2).
A total of 149 non-repetitive isolates were analyzed out
of which 72 E. faecalis species were isolated from urine (67),
pus (1), blood (1), vagina (2) and sterile body fluid (1) sam-
ples, and 31 E. faecium species were isolated from pus (3),
blood (2) and urine (26) samples.
Clinical samples were identified aseptically in the pa-
tients of Milad hospital. The results of these studies
showed that the dominant species was E. faecalis followed
by E. faecium. All of the 149 Enterococcus isolates were tested
by disc diffusion method and the results are shown in Table
3.
As indicated in the Table 3, the highest resistance was
observed against gentamicin in all species followed by ery-
thromycin and tetracycline in Enterococcus faecium and
E. faecalis, respectively. While minimal resistance to van-
comycin was observed too.
About 33 strains of VRE, E. faecium, almost half of the
resistant strains, were allocated and then, E. faecalis was
in the second place. Enterococcus faecalis strains showed
the highest resistance to gentamicin. Susceptibility pat-
terns of the isolates are shown in Table 4. Results showed
that six isolated strains were resistant to all antibiotics in-
cluding ampicillin (AMP), gentamicin (GEN), ciprofloxacin
(CIP), erythromycin (ERY), vancomycin, chloramphenicol
(CHL) and tetracycline (TCY). Meanwhile, more than 34 iso-
lated strains were resistant to five antibiotics including
vancomycin, tetracycline, gentamicin, ciprofloxacin and
erythromycin. However, 22 strains were resistant to seven
categories of various antibiotics. The interesting point was
that eight isolates were resistant to only three antibiotics.
Results also showed sensitivity to other antibiotics; of the
149 tested Enterococcus strains, 91 were susceptible to van-
comycin (MIC ≤ 4 mg/mL), nine were intermediate (MIC
Arch Clin Infect Dis. 2016; 11(3):e36260. 3
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Table 2. Distribution of Enterococcus spp.
Code Organism Number of Isolates (%) Number of Patients f m
efa Enterococcus faecalis 118 60 79 50 68
efm Enterococcus faecium 20 26 13 14 6
ent Enterococcus spp. 11 14 7 8 3
Table 3. Resistance to Different Antibiotics Among Enterococcus faecium, Enterococcus faecalis and Enterococcus spp.
Antibiotic Name Breakpoints Number %R %I %S % R 95%CI
fcla fcmb entc fcl fcm ent fcl fcm ent
Penicillin G S≥ 15 149 27.1 55 36.4 0 0 0 72.9 45 63.6 24.3 - 39.7
Ampicillin S≤ 8; R≥ 16 149 26.3 65 27.3 0 0 0 73.7 35 72.7 24.3 - 39.7
Ampicillin S≥ 17 149 24.6 50 0 0 0 0 75.4 50 100 19.5 - 34.1
Gentamicin 13 - 14 149 77.1 80 63.6 5.9 0 0 16.9 20 45.5 68.0 - 82.3
Ciprofloxacin 16 - 20 149 49.2 75 54.5 33.9 15 27.3 16.9 10 9.1 45.4 - 61.8
Erythromycin 14 - 22 149 69.5 80 54.5 27.1 15 45.5 3.4 5 0 61.7 - 76.9
Vancomycin S≤ 4; R≥ 32 149 28 60 27.3 6.8 5 9.1 65.3 35 63.6 24.9 - 40.4
Vancomycin 15 - 16 149 14.4 50 18.2 28 15 18.2 57.6 35 63.6 13.7 - 27.0
Chloramphenicol 13 - 17 149 33.9 40 9.1 14.4 5 27.3 51.7 55 63.6 25.6 - 41.1
Tetracycline 15 - 18 149 72 70 63.6 6.8 5 9.1 21.2 25 27.3 63.0 - 78.1
a fcl, Enterococcus faecalis.
b fcm, Enterococcus faecium.
c ent, Enterococcus spp.
= 8 µg/mL for both strains), and 49 were resistant (MIC≥
32 mg/mL). The importance of this information lies in the
fact that Enterococcus spp. are often potential pathogens
of mixed infections for a broad-spectrum antimicrobial
agents such as ciprofloxacin and ampicillin.
After the initial identification of different species, the
identified species were confirmed by PCR.
Furthermore, PCR was performed on virulence induc-
ing genes. According to the results of the current study
shown in Table 5, the esp gene was the most widespread
virulence determinant. The gelE was harbored only in 2%
of the isolates. The result showed that the ace gene, encod-
ing collagen-binding protein, was found in high frequency
among E. faecalis isolates. Forty five isolates of E. faecalis
and three isolates of E. faecium had cylA gene.
5. Discussion
The current study describes the isolation, biochemical
and molecular characterization of intrinsically Enterococ-
cus spp. from urine, blood, pus, stool, fluids and aspirates
clinical samples collected from patients admitted to ICU,
emergency and surgery rooms of Milad hospital.
Although the prevalence of VRE strains in poultry, food
and water were more varied studies also showed that E. fae-
calis and E. faecium strains are more common (14).
Figure 1. Agarose Gel Electrophoresis of Amplified cylA, esp and gelE by Multiplex
PCR and ace by Simple PCR
Lane 1, 1 kb DNA ladder; lanes 2, 3, positive controls for esp (510 bp) and gelE (210 bp);
lane 4, isolates positive for gelE (213 bp) and esp (510 bp); lane 5, positive controls for
esp (510 bp) and cylA (670 bp); lanes 6, 7, isolates positive for esp (510 bp ) and cylA
(670 bp); lane 11 - 15: isolate positive for ace (616 bp ); lane 16, positive control for ace
(616 bp).
The current study found E. faecalis the predominant de-
tected species with a higher prevalence, as expected. Other
studies reported similar results. In comparison to other
studies worldwide, resistance of E. faecium to all studied
antibiotics was higher than those of E. faecalis. VRE was
higher in E. faecium than E. faecalis and E. faecium.
Resistance to multiple classes of antibiotics was com-
mon in Enterococcus spp. as observed in this research.
The resistance rate to ciprofloxacin and chloramphenicol
among E. faecalis was more than that of E. faecium. This may
4 Arch Clin Infect Dis. 2016; 11(3):e36260.
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Table 4. Resistance Profile of the Isolates to the Studied Antibiotics
Samples Resistance Profile
1 CIP
3 ERY
1 ERY, CIP
1 ERY, CIP, AMP, PEN
2 ERY, GEN
1 ERY, GEN, PEN
2 ERY, GEN, CIP
2 ERY, GEN, CIP, PEN
1 ERY, GEN, CIP, AMP
1 ERY, GEN, CIP, AMP, PEN
1 GEN
1 TCY, GEN, CIP, PEN
2 TCY, ERY
3 TCY, ERY, GEN
8 TCY, ERY, GEN, CIP
5 TCY, ERY, GEN, CIP, PEN
8 TCY, ERY, GEN, CIP, AMP, PEN
1 TCY, ERY, CHL, GEN, CIP
3 TCY, ERY, CHL, GEN, CIP, PEN
1 TCY, ERY, CHL, GEN, CIP, AMP
3 TCY, ERY, CHL, GEN, CIP, AMP PEN
1 VAN, ERY
2 VAN, ERY, PEN
1 VAN, ERY,AMP, PEN
1 VAN, ERY, CIP, AMP, PEN
4 VAN, ERY, GEN, CIP, AMP, PEN
1 VAN, ERY, CHL, GEN, CIP, AMP, PEN
2 VAN, TCY, CIP
5 VAN, TCY, ERY, GEN, CIP
3 VAN, TCY, ERY, GEN, CIP, PEN
9 VAN, TCY, ERY, GEN, CIP, AMP PEN
1 VAN, TCY, ERY, CHL, CIP, PEN
1 VAN, TCY, ERY, CHL, CIP, AMP PEN
1 VAN, TCY, ERY, CHL, GEN, PEN
9 VAN, TCY, ERY, CHL, GEN, CIP
2 VAN, TCY, ERY, CHL, GEN, CIP, PEN
1 VAN, TCY, RY CHL, GEN, CIP, AMP
23 VAN, TCY, ERY, CHL, GEN, CIP, AMP, PEN
AMP, ampicillin; CIP, ciprofloxacin; CHL, chloramphenicol; ERY, erythromycin; GEN, gentamicin; PEC, penicillin; TCY, tetracycline; VAN, vancomycin
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Table 5. Distribution of Different Virulence Genes Among Enterococcus Isolates
Virulence Gene No. Total
Fcla fcmb entc
gel E 3 0 0 3
ace 53 4 2 59
cylA 45 3 0 48
esp 80 9 5 94
afcl, Enterococcus faecalis.
bfcm, Enterococcus faecium.
cent, Enterococcus spp.
be because of indiscriminate use of these two antimicro-
bials in human and animal infections and selective pres-
sure or simply the transfer of resistance genes or a combi-
nation of both (26).
Maschieto et al. reported that the distribution of En-
terococcus spp. isolated from the intestinal tracts of pa-
tients referred to a university affiliated hospital in Brazil
was E. faecium (34%) followed by E. faecalis (33%), E. galli-
narum (23.7%), E. casseliflavus (5.2%), E. avium (1%) and E. hirae
(1.2%) (27).
These results are consistent with other studies con-
ducted in Iran and in environmental samples (24). This
may be due to the ability of resistance to antimicrobial
agents and because of that the bacteria is one of the most
opportunistic pathogens. Prolonged hospital stay, inap-
propriate use of antibiotics such as cephalosporin and van-
comycin, use of antimicrobial growth promoters such as
avoparcin in animal food, organ transplantation, using
metronidazole, surgery, diabetes and leukemia for some
reasons can be a predisposing factor in colonization or in-
fection with these microorganisms. According to the evi-
dences, VRE can be transmitted horizontally from human
to human and animal to human (26).
In the current study, 32.2% of the isolates were resis-
tant to vancomycin. Compared with other studies con-
ducted worldwide, this amount is different and variable.
The study by Gambarotto et al. showed that the prevalence
of VRE in hematology patients was about 37% (25).
Kuhn et al. showed that the prevalence of VRE isolated
from animals, humans and the environment in different
European regions was in the range of 8% - 11% (16).
The study by Martinez et al. showed significant
relationship between antibiotic usage (vancomycin,
cephalosporin, metronidazole and quinolones) and
emergence of VRE (28).
In the United States, VRE isolates are restricted to hos-
pitalized patients, whereas in European countries VRE are
isolated from different environments (29). The prevalence
of vancomycin resistant strains in Europe and the United
States is in association with the excessive use of glycopep-
tide antibiotics in health centers due to the isolation of
these bacteria from human gut and colonization in the
gastrointestinal tract or transferring the resistance genes
to microorganisms of digestive tract; while the transition
and use of growth promoters such as avoparcin as a food
supplement for livestock and poultry (26).
The release of the microorganism takes place from pa-
tient to patient via the contaminated hands of personnel.
The bacteria remain alive on the hands for 30 minutes. It is
difficult to eliminate even a VRE from a hospital (30).
About 53.7% of the strains were resistant to
ciprofloxacin and 32.2% were resistant to vancomycin.
This antibiotic is widely used due to the success in the
treatment of urinary tract infections. In 2000, a report
in Greece showed that E. faecium had grater resistance to
antibiotics (three times more) than Enterococcus faecalis
(21).
Resistance to erythromycin in the current study was
69% of the reported strains that was due to the uncon-
trolled use of these antibiotics in Iran. Erythromycin is an
antibiotic used in the food industry that affects resistance
in Enterococcus spp. (18). Stobberingh et al. showed that re-
sistance to vancomycin in clinical and environmental sam-
ples was 12% and 12%, respectively (31).
In general, the rate of VRE strains resistant to gentam-
icin was reported 86.6% and about 76%. As predicted, most
of E. faecium strains were resistant to gentamicin. How-
ever, Khan et al. reported that resistance to gentamicin was
about 96% in America (23).
In the current study, 71.1% of the strains were resistant
to tetracycline and 32.2% were resistant to vancomycin.
The overall level of resistance to tetracycline in the world
is highly variable. In this study, the lowest resistance be-
longed to vancomycin.
On the other hand, Enterococcus species have the abil-
ity to reproduce and survive in soil and water. Therefore, a
6 Arch Clin Infect Dis. 2016; 11(3):e36260.
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lot of attention should be paid to prevent transmission of
microorganisms in the nature.
In the present study, resistance to penicillin was ob-
served in 27.1% of E. faecalis and 55% of E. faecium (Table 3).
Antibiotic resistance alone cannot explain the viru-
lence of Enterococcus spp. In order to become pathogenic,
they need to express virulence traits associated with adhe-
sion, translocation and evasion of immune responses and
cause pathological changes (32).
In the present study, ace, esp, cylA and gelE genes were
detected with 39.5%, 61.7%, 32.2% and 2% in isolated strains,
respectively. In general, the incidence of these virulence
traits was lower among E. faecium strains than E. faecalis
strains. The four examined genes were more prevalent in
Enterococcus faecalis than in Enterococcus faecium.
According to the results of the current study, E. faecium
strains isolated from clinical samples had lower potential
pathogenicity than those of the E. faecalis. However, viru-
lence genes in E. faecalis isolates were more variable.
Authors observed a considerable number of E. faecalis
harboring esp compared with cylA and gelE genes. Shankar
et al. showed that 29% of the blood isolates and 42% of en-
docarditis E. faecalis isolates were positive for the esp gene,
while only 3% of species isolated from stool showed this
trait (33).
In the present investigation, the esp gene, which en-
codes enterococcal surface protein, was found in high fre-
quency among E. faecalis strains (Table 5). A high incidence
of this gene in E. faecalis was reported in previous studies
(34).
The contribution of the surface protein Esp to coloniza-
tion and insistence of E. faecalis in urinary tract infections
was observed in an animal model (33).
Franz et al. previously reported that the presence of vir-
ulence factors is a strain specific character (35). Similarly, a
high distribution of the gelE gene in E. faecalis was reported
by Mannu et al. (36).
Only 20% of the E. faecium strains but 44.9% of the E.
faecalis strains produced ace (Table 5).
Conversely, a study on food and medical isolates
showed the incidence of esp in clinical E. faecium isolates
is more than that of E.faecalis (32).
Vancomycin resistance was not associated with more
virulent strains in the current study. In fact, according to
Giridhara Upadhyaya et al. (37) there is insignificant differ-
ence in virulence factors, ability to cause infection or van-
comycin susceptibility among Enterococcus isolates.
In the current study, gelE significantly enriched in E.
faecalis isolates in comparison with E. faecium and may
involve in the creation of a urinary tract infection (P <
0.001). The obtained results showed that, gelE-positive E.
faecalis isolates had less frequency in clinical isolates and
not found in any of the E. faecium isolates. Likewise, previ-
ous studies on E. faecalis demonstrated high expression of
this gene among the isolates (8, 34).
5.1. Conclusion
There were some limitations in the current study such
as small sample size, short duration of study, and inability
to detect different strains of Enterococcus spp. The results of
the study indicated that more research is needed to char-
acterize molecular and cellular interactions between the
host and Enterococcus isolates which lead to intra-species
genetic transfer and virulence factors. The identification of
virulence factors associated with invasiveness and disease
severity is an important subject for research.
A better understanding of the role of the virulence fac-
tors of Enterococcus spp. in nosocomial infections may help
to improve new strategies to prevent or reduce the infec-
tion by this species.
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